rs761311570
Variant names:
Variant summary
Our verdict is Benign. The variant received -21 ACMG points: 0P and 21B. BP4_StrongBP6_Very_StrongBP7BS1BS2
The NM_173354.5(SIK1):c.1926C>T(p.Ala642Ala) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★).
Frequency
Genomes: 𝑓 0.00017 ( 2 hom., cov: 1)
Exomes 𝑓: 0.00012 ( 11 hom. )
Failed GnomAD Quality Control
Consequence
SIK1
NM_173354.5 synonymous
NM_173354.5 synonymous
Scores
2
Clinical Significance
Conservation
PhyloP100: -1.22
Publications
0 publications found
Genes affected
SIK1 (HGNC:11142): (salt inducible kinase 1) This gene encodes a serine/threonine protein kinase that contains a ubiquitin-associated (UBA) domain. The encoded protein is a member of the adenosine monophosphate-activated kinase (AMPK) subfamily of kinases that play a role in conserved signal transduction pathways. A mutation in this gene is associated with early infantile epileptic encephalopathy 30. [provided by RefSeq, Nov 2016]
SIK1 Gene-Disease associations (from GenCC):
- developmental and epileptic encephalopathy, 30Inheritance: AD Classification: DEFINITIVE, STRONG Submitted by: G2P, Labcorp Genetics (formerly Invitae)
- genetic developmental and epileptic encephalopathyInheritance: AD Classification: STRONG, SUPPORTIVE, LIMITED Submitted by: Orphanet, ClinGen, PanelApp Australia
- early myoclonic encephalopathyInheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
- infantile spasmsInheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
- generalized epilepsyInheritance: AD Classification: LIMITED Submitted by: Ambry Genetics
Genome browser will be placed here
ACMG classification
Classification was made for transcript
Our verdict: Benign. The variant received -21 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.88).
BP6
Variant 21-43417593-G-A is Benign according to our data. Variant chr21-43417593-G-A is described in ClinVar as Benign/Likely_benign. ClinVar VariationId is 476094.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BP7
Synonymous conserved (PhyloP=-1.22 with no splicing effect.
BS1
Variant frequency is greater than expected in population nfe. GnomAd4 allele frequency = 0.000166 (6/36148) while in subpopulation NFE AF = 0.000221 (3/13552). AF 95% confidence interval is 0.0000595. There are 2 homozygotes in GnomAd4. There are 1 alleles in the male GnomAd4 subpopulation. Median coverage is 1. This position passed quality control check.
BS2
High AC in GnomAd4 at 6 AD gene.
Variant Effect in Transcripts
ACMG analysis was done for transcript: NM_173354.5. You can select a different transcript below to see updated ACMG assignments.
Ensembl Transcripts
| Sel. | Gene | Transcript | Tags | HGVSc | HGVSp | Effect | Exon Rank | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|---|
| SIK1 | TSL:1 MANE Select | c.1926C>T | p.Ala642Ala | synonymous | Exon 13 of 14 | ENSP00000270162.6 | P57059 | ||
| SIK1 | c.1779C>T | p.Ala593Ala | synonymous | Exon 12 of 13 | ENSP00000550949.1 | ||||
| SIK1 | c.1644C>T | p.Ala548Ala | synonymous | Exon 12 of 13 | ENSP00000550948.1 |
Frequencies
GnomAD3 genomes AF: 0.000166 AC: 6AN: 36148Hom.: 2 Cov.: 1 show subpopulations
GnomAD3 genomes
AF:
AC:
6
AN:
36148
Hom.:
Cov.:
1
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD2 exomes AF: 0.0000705 AC: 9AN: 127680 AF XY: 0.0000838 show subpopulations
GnomAD2 exomes
AF:
AC:
9
AN:
127680
AF XY:
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome Data not reliable, filtered out with message: AS_VQSR AF: 0.000125 AC: 22AN: 176244Hom.: 11 Cov.: 0 AF XY: 0.0000901 AC XY: 8AN XY: 88808 show subpopulations
GnomAD4 exome
Data not reliable, filtered out with message: AS_VQSR
AF:
AC:
22
AN:
176244
Hom.:
Cov.:
0
AF XY:
AC XY:
8
AN XY:
88808
show subpopulations
African (AFR)
AF:
AC:
0
AN:
8650
American (AMR)
AF:
AC:
0
AN:
1700
Ashkenazi Jewish (ASJ)
AF:
AC:
0
AN:
4740
East Asian (EAS)
AF:
AC:
0
AN:
6202
South Asian (SAS)
AF:
AC:
0
AN:
10334
European-Finnish (FIN)
AF:
AC:
0
AN:
3906
Middle Eastern (MID)
AF:
AC:
0
AN:
718
European-Non Finnish (NFE)
AF:
AC:
22
AN:
130318
Other (OTH)
AF:
AC:
0
AN:
9676
Age Distribution
Exome Hom
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome AF: 0.000166 AC: 6AN: 36148Hom.: 2 Cov.: 1 AF XY: 0.0000598 AC XY: 1AN XY: 16736 show subpopulations
GnomAD4 genome
AF:
AC:
6
AN:
36148
Hom.:
Cov.:
1
AF XY:
AC XY:
1
AN XY:
16736
show subpopulations
African (AFR)
AF:
AC:
3
AN:
16200
American (AMR)
AF:
AC:
0
AN:
2164
Ashkenazi Jewish (ASJ)
AF:
AC:
0
AN:
1040
East Asian (EAS)
AF:
AC:
0
AN:
768
South Asian (SAS)
AF:
AC:
0
AN:
1054
European-Finnish (FIN)
AF:
AC:
0
AN:
618
Middle Eastern (MID)
AF:
AC:
0
AN:
80
European-Non Finnish (NFE)
AF:
AC:
3
AN:
13552
Other (OTH)
AF:
AC:
0
AN:
468
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.450
Heterozygous variant carriers
0
0
1
1
2
2
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Alfa
AF:
Hom.:
ClinVar
ClinVar submissions
View on ClinVar Significance:Benign/Likely benign
Revision:criteria provided, multiple submitters, no conflicts
Pathogenic
VUS
Benign
Condition
-
-
1
Developmental and epileptic encephalopathy, 30 (1)
-
-
1
Inborn genetic diseases (1)
-
-
1
not provided (1)
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
DANN
Benign
PhyloP100
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at
Publications
You must be logged in to view publications. This limit was set because tens of millions (!) of queries from AI bots are generated daily.